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Modern imaging of the pancreas has both a morpholo-
gic role, with an accurate delineation of the pancreatic
tissue as well as of the pancreatic ducts and vessels, and
a functional role, with the visualization of the pancreatic
fluid cynetic and ductal dilation after secretin injection.
The wide range of informations achievable with mod-
ern imaging techniques leads to a in depht knowledge
of the different diagnostic value obtained by different
imaging techniques.
US is conventionally the first-line diagnostic tool to be
used in patients with jaundice or abdominal pain, but
with a low sensitivity and specificity, as the imaging fea-
ture of a hypoechoic mass cannot provide useful infor-
mation to differentiate pancreatic cancer from mass-
forming pancreatitis. Moreover, artifacts inside cavities
can lead to difficulties in differentiating small cystic
lesions from solid ones, or a false diagnosis of inhomo-
geneous content of cystic lesions. With Tissue Harmo-
nic Imaging (THI) a reduction of artefacts inside cystic
lesions can be obtained, allowing a better confidence in
the nature of small hypoechoic lesions of the pancreas
and a better fluid-solid differentiation. Acoustic Radia-
tion Force Impulse (ARFI) technique allows to evaluate
the mechanical strain properties of deep organs by
means of a focused high intensity pulse to displace the
target tissue. It has been utilized in the evaluation of
acute pancreatitis, in the differentiation of benign and
malignant focal pancreatic solid lesions, in the evalua-
tion of the content of cystic pancreatic lesions [1-3].
Finally, CEUS has improved the characterization of
pancreatic tumors, allowing a better differentiation
between pancreatic carcinoma and mass-forming pan-
creatitis, adenocarcinoma and neuroendocrine tumor,
serous and mucinous cystic pancreatic lesions [4].
MDCT is a robust technique to explore the pancreas,
and it is the gold standard in the local staging of pan-
creatic carcinoma, thanks to its high spatial resolution,
which allows a good depiction of the relationship of the
tumor with the peri-pancreatic vessels. However, small
iso-attenuating tumors can be hardly depicted with CT.
New protocols with low-kV or dual energy technique
improve the sensitivity of the MDCT, thus allowing the
depiction of small tumors [5,6], especially with the use
of new algorithms, which reduce the noise [7].
MRI it is used as a “problem solving” technique, when
other imaging modalities are not able to resolve the
clinical question, although in the evaluation of cystic
tumor of the pancreas it is considered the gold standard,
thanks to its high sensitivity to static fluids and different
composition of fluids (mucin, blood, etc.). The most sig-
nificant application of MR in the pancreas are:
- When dealing with Acute Pancreatitis (AP), MR can
be the highly accurate in the evaluation of both intra-
ed extrapancreatic hemorrhagic/fluid collections.
- MRCP can permit the detection of either acquired
(e.g. calculi) or congenital (pancreas divisum) causes of
AP, especially after the administration of secretin. This
can be particularly useful in case of recurrent AP.
- In Chronic Pancreatic (CP), MRCP enables the dis-
tinction between primitive and obstructive causes.
Moreover, the functional informations obtained with
MRCP after secretin injection is able to suggest the
forthcoming onset of a CP when the morphological
changes are still not evident.
- In the differential diagnosis between pancreatic carci-
noma and mass-forming pancreatitis, morphological,
ductal, functional information as well as DWI with
IVIM analysis are becoming important tools to achieve
a correct diagnosis [8].
- DWI also useful improves diagnostic accuracy for
differentiating malignant from benign IPMNs of the
pancreas [9].
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